PetaGen is a joint venture between ISU Chemical and one of top three medical centers in Korea. Established in 2001, PetaGen is a clinical laboratory that develops and markets innovative technologies and services for unmet medical needs. Backed by the resources and medical expertise of two organizations, our business is firstly focused on developing technologies for genetic tests, and anticancer drug screening service. We provide automated DNA sequencing, fragment analysis for molecular biological services for medical doctors, and also develop anticancer drug screening technologies for individual cancer patients. We will focus target disease firstly on genetic disorders, secondly on cancers. In addition, we will develop biomarkers to diagnose a number of specific diseases, and new drug target, using antibody display technology proteomics, with prominent research institutions in Korea and abroad.